Sucampo announced that Rescula (unoprostone isopropyl ophthalmic solution) 0.15% is now available. Rescula is approved for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Rescula is a synthetic docasanoid that activates big potassium (BK) channels in the eye. BK channels are expressed in contractile tissues like the trabecular meshwork. Rescula may reduce elevated intraocular pressure by increasing the outflow of aqueous humor through the trabecular meshwork.
Rescula 0.15% is available in a 5mL solution in a 7.5mL bottle.
For more information call (301) 961-3400 or visit www.rescula.com